Gabales, Lulito, JR.. C.
HRN: 24-89-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/11/2024
06/18/2024
IV
500mg
Q8H
S/P ExLap
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes